Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods-Reference-Cited by-同舟云学术

Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles—Part 2: Mass spectrometric methods

Published:2015-05-21 Issue:4 Volume:7 Page:732-742
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Reusch Dietmar,Haberger Markus,Falck David,Peter Britta,Maier Bernd,Gassner Jana,Hook Michaela,Wagner Katharina,Bonnington Lea,Bulau Patrick,Wuhrer Manfred

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.1080/19420862.2015.1045173

Reference27 articles.

1. Trends in Glycosylation, Glycoanalysis and Glycoengineering of Therapeutic Antibodies and Fc-Fusion Proteins

2. Editorial [Hot Topic: Therapeutic Antibodies and Derivatives: From the Bench to the Clinic(Guest Editor: Alain Beck)]

3. Therapeutic Antibodies: Current State and Future Trends – Is a Paradigm Change Coming Soon?

4. Glycosylation as a strategy to improve antibody-based therapeutics

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments;Communications Chemistry;2024-09-12

2. Expanding the structural resolution of glycosylation microheterogeneity in therapeutic proteins by salt-free hydrophilic interaction liquid chromatography tandem mass spectrometry;mAbs;2024-08-27

3. Comparative analysis of Herceptin N-Linked glycosylation by HILIC-FLD and LC-MS/MS methods;Journal of Pharmaceutical and Biomedical Analysis;2024-07

4. Comprehensive analysis and characterization of glycan pairing in therapeutic antibodies and Fc-containing biotherapeutics: Addressing current limitations and implications for N-glycan impact;European Journal of Pharmaceutics and Biopharmaceutics;2024-07

5. Functional characterization of AF-04, an afucosylated anti-MARV GP antibody;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02